Ask AI
ProCE Banner Events

Share

MISSION POSSIBLE: Elevating Risk Recognition, Treatment Decisions, and Pancreatitis Prevention in Severe Hypertriglyceridemia

Severe hypertriglyceridemia (sHTG) presents ongoing challenges in risk recognition, treatment selection, and prevention of acute pancreatitis. As guidelines evolve and novel therapies emerge, healthcare professionals need to understand how new evidence can inform patient care.

Join expert faculty for a live, interactive symposium exploring the latest evidence and practical strategies to assess risk, optimize triglyceride-lowering therapy, navigate emerging treatments, and reduce the likelihood of acute pancreatitis in patients with sHTG.

This event is not part of the official Scientific Sessions Conference 2026 as planned by the American Heart Association Committee on Scientific Sessions Programming.

Physicians: maximum of 1.50 AMA PRA Category 1 Credits™

Physician Assistants/Physician Associates: 1.50 AAPA Category 1 CME credits

Nurse Practitioners/Nurses: 1.50 Nursing contact hours

Who Should Attend

This activity is intended for cardiology physicians, NPs, PAs, and other healthcare professionals involved in the care of patients with sHTG.

Time and location

Sunday, November 08, 2026

6:00 AM - 8:00 AM Central Time (CT)

In-person

6:30 AM - 8:00 AM Central Time (CT)

Virtual

McCormick Place Convention Center
2301 S. Dr. Martin Luther King Jr. Drive
Chicago, Illinois 60616

Industry Meeting Room, Level 4, N427D

Agenda

  • Welcome, Opening Remarks, and Baseline Assessment 
  • MISSION BRIEFING: Identify the Threat 
  • MISSION OBJECTIVE: Find a Way Forward 
  • MISSION POSSIBLE: The Clinical Challenge—What’s Your Next Move? 
  • Postassessment and Evaluation 
  • Key Takeaways and Q&A Session 

Location

Venue Name

McCormick Place Convention Center

Address

McCormick Place Convention Center
2301 S. Dr. Martin Luther King Jr. Drive
Chicago, Illinois 60616

Room Name

Industry Meeting Room, Level 4, N427D

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Dyslipidemia.

Target Audience
This activity is intended for cardiology physicians, NPs, PAs, and other healthcare professionals involved in the care of patients with sHTG.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify patients with severe hypertriglyceridemia (sHTG) through appropriate risk assessment, lipid evaluation, and recognition of key clinical indicators

  • Assess current and emerging treatment approaches for severe hypertriglyceridemia, incorporating patient-specific cardiovascular risk factors and comorbidities

  • Apply guideline-based management strategies to optimize triglyceride lowering, improve cardiometabolic health, and reduce the likelihood of acute pancreatitis in patients with sHTG

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporter

This activity is supported by Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

Contact Information

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191

 

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.